James Shin
Stock Analyst at Deutsche Bank
(1.94)
# 3,051
Out of 4,941 analysts
22
Total ratings
44.44%
Success rate
5.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintains: Buy | $1,010 → $900 | $639.61 | +40.71% | 5 | Aug 11, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $6.42 | +55.76% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $119.68 | +0.27% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $80.08 | +31.12% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $285.00 | +7.02% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $81.70 | -26.56% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $46.44 | -3.10% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $36.79 | +63.09% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $198.60 | -24.47% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $555.16 | +44.10% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.19 | +357.67% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.79 | +1,425.75% | 1 | Nov 9, 2023 |
Eli Lilly and Company
Aug 11, 2025
Maintains: Buy
Price Target: $1,010 → $900
Current: $639.61
Upside: +40.71%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $6.42
Upside: +55.76%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $119.68
Upside: +0.27%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $80.08
Upside: +31.12%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $285.00
Upside: +7.02%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $81.70
Upside: -26.56%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $46.44
Upside: -3.10%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $36.79
Upside: +63.09%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $198.60
Upside: -24.47%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $555.16
Upside: +44.10%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $2.19
Upside: +357.67%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $0.79
Upside: +1,425.75%